🇺🇸·2h agoIndustry
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
Publisher
E
Eli Lilly News
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on investor.lilly.com
Leave the platform to read the original full article on the publisher site.
Source: Eli Lilly News
Scope: Industry
Related coverage
More related coverage
GSK News·6h ago
TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation
Monash Health·7h ago
Building confidence through cricket: Tooradin’s Wellness Through Wickets success
Astellas Pharma·7h ago
Financial Results of Astellas for FY2025
Astellas Pharma·7h ago